Similar articles

• Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.

  Flaker GC, Eikelboom JW, Shestakovska O, Connolly SJ, Kaatz S, Budaj A, Husted S, Yusuf S, Lip GY, Hart RG. Flaker GC, et al. Stroke. 2012 Dec;43(12):3291-7. doi: 10.1161/STROKEAHA.112.664144. Epub 2012 Oct 2. Stroke. 2012. PMID: 23033347 Clinical Trial.
• Warfarin: an inconvenient truth.

  Gattellari M, Worthington J, Zwar N. Gattellari M, et al. Stroke. 2009 Jan;40(1):5-7. doi: 10.1161/STROKEAHA.108.527903. Epub 2008 Aug 28. Stroke. 2009. PMID: 18757283 No abstract available.
• The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.

  Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN. Lee BH, et al. J Cardiovasc Electrophysiol. 2010 May;21(5):501-7. doi: 10.1111/j.1540-8167.2009.01661.x. Epub 2009 Dec 15. J Cardiovasc Electrophysiol. 2010. PMID: 20021521
• Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice.

  Sabir IN, Matthews GD, Huang CL. Sabir IN, et al. Postgrad Med J. 2013 Jun;89(1052):346-51. doi: 10.1136/postgradmedj-2012-131386. Epub 2013 Feb 12. Postgrad Med J. 2013. PMID: 23404744 Free PMC article. Review.
• Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

  Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee. Cairns JA, et al. Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007. Can J Cardiol. 2011. PMID: 21329865